| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| triflupromazine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.36 | approved,vet_approved | antagonist |
| triflupromazine | muscarinic acetylcholine receptor m1 | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.36 | approved,vet_approved | antagonist |
| triflupromazine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.48 | approved,vet_approved | antagonist |
| triflupromazine | muscarinic acetylcholine receptor m2 | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.48 | approved,vet_approved | antagonist |
| triflupromazine | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.39 | approved,vet_approved | antagonist |
| triflupromazine | dopamine d1 receptor | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.39 | approved,vet_approved | antagonist |
| triflupromazine | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.36 | approved,vet_approved | antagonist |
| triflupromazine | dopamine d2 receptor | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.36 | approved,vet_approved | antagonist |
| triflupromazine | 5-ht 2b receptor | NA | Successful target | TTD , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.82 | approved | unknown |
| triflupromazine | 5-ht 2b receptor | NA | Successful target | TTD , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.82 | approved | unknown |
| triflupromazine | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Severe Acute Respiratory Syndrome[MeSHID:D045169] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Schizophrenia[MeSHID:D012559] Middle East Respiratory Syndrome[MeSHID:D018352] |
0.82 | approved,vet_approved | antagonist |
| triflupromazine | 5-hydroxytryptamine receptor 2b | small molecule | NA | drugbank , DGIDB | Nausea[MeSHID:D009325] Disease Management[MeSHID:D019468] Psychotic Disorders[MeSHID:D011618] Vomiting[MeSHID:D014839] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
0.82 | approved,vet_approved | antagonist |
| click here to return to the previous page | ||||||||